By Benjamin Chiou
Date: Tuesday 22 Jul 2025
(Sharecast News) - French pharma giant Sanofi announced on Tuesday that it is to purchase London-based respiratory virus vaccine developer Vicebio for up to $1.6bn.
No recent information was found.
Currency | Euro |
Share Price | 80.34 |
Change Today | 1.50 |
% Change | 1.90 % |
52 Week High | 109.62 |
52 Week Low | 76.78 |
Volume | 3,746,341 |
Shares Issued | 1,256.00m |
Market Cap | 100,907m |
Beta | 0.79 |
Strong Buy | 13 |
Buy | 6 |
Neutral | 8 |
Sell | 0 |
Strong Sell | 0 |
Total | 27 |
Time | Volume / Share Price |
17:37 | 451 @ 80.34 |
17:36 | 710 @ 80.34 |
17:36 | 131 @ 80.34 |
17:36 | 100 @ 80.34 |
17:36 | 10 @ 80.34 |
You are here: research